Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 43,454	$ 32,412
Short-term investments	47,582	20,821
Accounts receivable	11,744	10,890
Inventories	10,252	6,933
Prepaid expenses and other current assets	6,498	2,704
Total current assets	119,530	73,760
Property, plant and equipment, net	3,166	1,790
Right-of-use assets	936	1,039
Total assets	123,632	76,589
Current liabilities
Accounts payable	2,658	961
Accrued expenses	8,191	5,078
Lease liabilities, current	101	105
Total current liabilities	10,950	6,144
Lease liabilities, non-current	835	933
Other liabilities, non-current	628	766
Total liabilities	12,413	7,843
Commitments and contingencies (see Note 13)
Stockholders’ equity
Preferred stock, $.01 par value; 10,000,000 shares authorized; 14,192 and 14,192 shares issued and outstanding at December 31, 2025 and 2024, respectively	0	0
Common stock, $.01 par value; 80,000,000 shares authorized; 34,691,671 shares and 33,061,002 shares issued and outstanding at December 31, 2025 and 2024, respectively	347	331
Additional paid-in capital	639,145	599,881
Accumulated deficit	(528,848)	(531,548)
Accumulated other comprehensive income	575	82
Total stockholders’ equity	111,219	68,746
Total liabilities and stockholders’ equity	$ 123,632	$ 76,589